Prism Medico & Pharmacy EV/EBITDA Ratio

Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio

The Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Prism Medico & Pharmacy Ltd's valuation, profitability, and overall financial performance. Tracking the Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Prism Medico & Pharmacy Ltd (NSE: , BSE: 512217) is currently trading at ₹24.75, with a market capitalization of ₹142.98M. As a leading company in the Finance sector and Financial conglomerates industry, monitoring the Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio Current Value

The current Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio stands at 0.

The Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.

Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

The decline in Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Prism Medico & Pharmacy Ltd.

Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Prism Medico & Pharmacy Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.